Purchase Order 75N92023P00338
- Not listed
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $177,991.20 firm fixed price purchase order to Metabolon, Inc., a self-certified small disadvantaged business, for metabolomic profiling of individuals of African descent. The order was issued directly under a solicitation, without the use of a set-aside. Metabolon provides metabolomics services and solutions to government agencies, leveraging its proprietary technology...
- The National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), awarded a $52,806 firm fixed-price purchase order to Metabolon, Inc. for Genomic Sample Study Analysis Services. The award, issued on September 12, 2025, with an ultimate completion date of September 11, 2026, represents a new contract without set-aside designation, making it available through full and open competition. Services will be performed in Bethesda, Maryland, with work to be...
- Metabolon, Inc., a small disadvantaged business, was awarded a $244,993.28 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute. The purpose is to perform metabolomic profiling of individuals of African descent with metabolic disorders, including a focus on comparing the metabolic profiles of those with high versus low triglyceride levels. This award is part of the Africa America Diabetes study and aims to integrate multiple omics...
- This is a firm fixed price purchase order contract awarded to Metabolon, Inc., a small disadvantaged business, by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute. The $279,378 contract is to provide metabolomics services to support the GENEFORECAST, SIT, and MHGRID research projects. Metabolon is an experienced provider of specialized metabolomics analysis capabilities for the federal government, having supported numerous...
- This is a firm-fixed price purchase order awarded by the National Institutes of Health's National Human Genome Research Institute to Metabolon, Inc., a small disadvantaged business, for the purpose of discovering diabetes metabolomics biomarkers in plasma and tissue samples from the NHGRI Fusion cohort clinical study, including meta-analysis with the METSIM cohort. The potential value of the contract is USD 376,105.00, with a completion date of May 29, 2019. Metabolon is a provider of...
- The NIH Clinical Center awarded a $24,784 firm fixed-price purchase order to Metabolon, Inc. for metabolomics analysis services. The contract, which commenced on September 9, 2025, with an ultimate completion date of September 8, 2026, represents a task order under Metabolon's existing Indefinite Delivery Contract with the NIH Clinical Center valued at $250,000. No set-aside designation was utilized for this award. Metabolon, a self-certified small disadvantaged business headquartered in...
- The National Institutes of Health's National Institute of Environmental Health Sciences awarded a $25,248 firm fixed price purchase order to Metabolon, Inc. for metabolomics analysis services in support of placode cell differentiation research. As the prime contractor, Metabolon will perform analysis on wild type and SMCHD1KO cells during placode cell development studies. The contract runs from September 1, 2023 through December 31, 2023 with all work conducted by Metabolon at its Morrisville,...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $56,132 purchase order to Metabolon, Inc. for metabolites testing services in support of an aging process and lipid mediators study related to HIV. Metabolon will perform the requested testing at its Morrisville, North Carolina facility between August 15 and October 31, 2023. This firm fixed price contract calls for Metabolon to deliver metabolites testing for lipid mediators to aid in the NIH's...
- This is a $160,000 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Metabolon, Inc., a small disadvantaged business. The contract is for metabolomic profiling of 800 plasma biospecimens collected from COVID-19 patients and appropriate controls, in order to generate metabolic profiles to support research initiatives related to the coronavirus pandemic. The contract was awarded...
- This is a $14,820 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS) National Institutes of Health (NIH), to Metabolon, Inc. The contract is for metabolomics analysis services to support research on the metabolic aspects of antiretroviral therapy (ART) initiation in patients with human immunodeficiency virus (HIV). Metabolon is a small disadvantaged business that...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $118,993 firm fixed price purchase order to Metabolon, Inc. to conduct research analyzing the metabolomic profile associated with cardiometabolic traits in African Americans. The contract has a period of performance from August 29, 2023 through August 28, 2024. Under the solicitation seeking this analysis, Metabolon will leverage its expertise in metabolomics to provide insights that further the NIH's mission to analyze the role of genetic and environmental factors in disease. This research supports the NIH's broader goals in the area of population health by deepening understanding of cardiometabolic conditions that disproportionately impact African American communities.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Metabolomic Profile Associated with Cardiometaboli | 75N92023Q0812 | Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute | Award Notice 2/2 | 8/29/23, 3:12 PM | |
Metabolomic Profile Associated with Cardiometaboli | 75N92023Q0812 | Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute | Solicitation 1/2 | 8/15/23, 2:43 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $119.0k | 8/29/23 |